Caribou Biosciences Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.
Others were interested in
See all stocksFrequently asked questions
To buy Caribou Biosciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Caribou Biosciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Caribou Biosciences Inc. is CRBU:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Caribou Biosciences Inc. has its primary listing on NASDAQ. You can trade Caribou Biosciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Caribou Biosciences Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Caribou Biosciences Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Caribou Biosciences Inc..